SCHEMBL6138940

SCHEMBL6138940

CCCCCCCCCCCCCCC(=O)CC(=O)OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.61
POLA1 P09884 1/20 0.61
HAO1 Q9UJM8 1/20 0.59
KMT2A Q03164 2/20 0.54
MAPT P10636 1/20 0.54
DGKA P23743 1/20 0.52
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
CA12 O43570 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
LMNA P02545 2/20 0.48
HSP90AA1 P07900 1/20 0.48
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3187580 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL1123527 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL6138719 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL1376494 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL6138711 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL18840606 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL6059806 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL1123664 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL6138959 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT
SCHEMBL3450636 1.00 POLB (0.61) POLBPOLA1HAO1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023752-B2 Conductive material and substrate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-07-17 US disclosed
US-20170174922-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-06-22 US disclosed
US-20170174922-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-06-22 US disclosed
US-20170130071-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
US-20170130070-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
US-20170130071-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
US-20170130070-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
EP-1176135-B1 Process for producing optically active alcohol TAKASAGO PERFUMERY CO LTD (JP) 2005-06-15 EP disclosed
US-6492545-B2 Process for producing optically active alcohol TAKASAGO INTERNATIONAL CORPORATION (JP) 2002-12-10 US disclosed
US-20020035283-A1 Process for producing optically active alcohol TAKASAGO INTERNATIONAL CORPORATION 2002-03-21 US disclosed
EP-1176135-A1 Process for producing optically active alcohol Takasago International Corporation (JP) 2002-01-30 EP disclosed
US-5945559-A REACTING AN ACETOACETIC ESTER WITH A CALCIUM, BARIUM OR STRONTIUM COMPOUND IN SOLVENT AND ACYLATION WITH A CARBOXYLICACID CHLORIDE, AND DEACYLATION WITH ALCOHOLS TAKASAGO INTERNATIONAL CORPORATION (JP) 1999-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035283-A1 Process for producing optically active alcohol ADH1A, ADH5, ADH1C POLB 2145/4885POLA1 1098/4885HAO1 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.